ArticleExperimental hematology & oncology2024

Combined inhibition of MET and VEGF enhances therapeutic efficacy of EGFR TKIs in EGFR-mutant non-small cell lung cancer with concomitant aberrant MET activation.

Shanshan Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.